{"id":"https://openalex.org/W2739944965","doi":"https://doi.org/10.1158/1538-7445.am2017-2046","title":"Abstract 2046: Investigation of MDR1 in ovarian cancer using biodynamic imaging","display_name":"Abstract 2046: Investigation of MDR1 in ovarian cancer using biodynamic imaging","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2739944965","doi":"https://doi.org/10.1158/1538-7445.am2017-2046","mag":"2739944965"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-2046","doi":"https://doi.org/10.1158/1538-7445.am2017-2046","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-2046","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007768372","display_name":"Gayatri Narayanan","orcid":"https://orcid.org/0000-0002-5091-4092","observed_orcids":["https://orcid.org/0000-0002-5091-4092"]},"institutions":[{"id":"https://openalex.org/I219193219","display_name":"Purdue University West Lafayette","ror":"https://ror.org/02dqehb95","country_code":"US","type":"education","lineage":["https://openalex.org/I219193219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gayatri Narayanan","raw_affiliation_strings":["1Purdue University, West Lafayette, IN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Purdue University, West Lafayette, IN;","institution_ids":["https://openalex.org/I219193219"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090690248","display_name":"David D. Nolte","orcid":"https://orcid.org/0000-0002-4872-9357","observed_orcids":["https://orcid.org/0000-0002-4872-9357","https://orcid.org/0000-0002-4098-5540"]},"institutions":[{"id":"https://openalex.org/I219193219","display_name":"Purdue University West Lafayette","ror":"https://ror.org/02dqehb95","country_code":"US","type":"education","lineage":["https://openalex.org/I219193219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David D. Nolte","raw_affiliation_strings":["1Purdue University, West Lafayette, IN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Purdue University, West Lafayette, IN;","institution_ids":["https://openalex.org/I219193219"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067743297","display_name":"Daniela Elena Matei","orcid":"https://orcid.org/0000-0003-2169-5035","observed_orcids":["https://orcid.org/0000-0003-2169-5035"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniela Matei","raw_affiliation_strings":["2Northwestern University, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Northwestern University, Chicago, IL;","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100319290","display_name":"Ran An","orcid":"https://orcid.org/0000-0002-4739-927X","observed_orcids":["https://orcid.org/0000-0002-4739-927X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ran An","raw_affiliation_strings":["3Animated Dynamics, Inc, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Animated Dynamics, Inc, Indianapolis, IN","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045894719","display_name":"John J. Turek","orcid":"https://orcid.org/0000-0003-4631-7356","observed_orcids":["https://orcid.org/0000-0003-4631-7356"]},"institutions":[{"id":"https://openalex.org/I219193219","display_name":"Purdue University West Lafayette","ror":"https://ror.org/02dqehb95","country_code":"US","type":"education","lineage":["https://openalex.org/I219193219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John J. Turek","raw_affiliation_strings":["1Purdue University, West Lafayette, IN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Purdue University, West Lafayette, IN;","institution_ids":["https://openalex.org/I219193219"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"2046","last_page":"2046"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9599999785423279,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9599999785423279,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11897","display_name":"Digital Holography and Microscopy","score":0.013399999588727951,"subfield":{"id":"https://openalex.org/subfields/3107","display_name":"Atomic and Molecular Physics, and Optics"},"field":{"id":"https://openalex.org/fields/31","display_name":"Physics and Astronomy"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.8809999823570251},{"id":"https://openalex.org/keywords/mdr1","display_name":"MDR1","score":0.9380000233650208},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9380000233650208},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/platinum-resistance","display_name":"platinum resistance","score":0.7089999914169312},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.8870000243186951},{"id":"https://openalex.org/keywords/tumor-spheroids","display_name":"tumor spheroids","score":0.796999990940094},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.7129999995231628},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.9660000205039978},{"id":"https://openalex.org/keywords/zosuquidar","display_name":"zosuquidar","score":0.9879999756813049},{"id":"https://openalex.org/keywords/drug-efflux-pumps","display_name":"drug efflux pumps","score":0.6809999942779541},{"id":"https://openalex.org/keywords/a2780-cells","display_name":"A2780 cells","score":0.7049999833106995}],"concepts":[{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.7062802314758301},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6784392595291138},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.589284360408783},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5734950304031372},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5431498885154724},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.5331945419311523},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.5073415637016296},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4959016740322113},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4599345028400421},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.44790714979171753},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4224739372730255},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4212021231651306},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3899770677089691},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36391133069992065},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3311438262462616},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25838375091552734},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-2046","doi":"https://doi.org/10.1158/1538-7445.am2017-2046","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-2046","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2783651255","https://openalex.org/W2494318518","https://openalex.org/W2004065634","https://openalex.org/W2104241850","https://openalex.org/W2095654922","https://openalex.org/W2264155967","https://openalex.org/W2369922198","https://openalex.org/W2074446996","https://openalex.org/W2016127643","https://openalex.org/W2401641521"],"abstract_inverted_index":{"Abstract":[0],"Multidrug":[1],"resistance":[2,40,73,148,165,206],"is":[3,41,65,104,138],"one":[4],"of":[5,9,12,17,35,59,79,108,129,163,199,293,330,357,360,377,393,434,445],"the":[6,30,36,42,50,80,188,288,298,326,380,390,446],"main":[7],"causes":[8],"ineffective":[10],"treatment":[11],"ovarian":[13,63,157,437],"cancer.":[14],"Almost":[15],"80%":[16],"advanced":[18],"cases":[19],"have":[20,169,345],"recurring":[21],"malignancies":[22],"after":[23,26,268],"treatment,":[24],"even":[25],"initial":[27],"responsiveness":[28],"to":[29,75,88,126,145,201,325,383,414],"usual":[31],"platinum-based":[32],"chemotherapeutics.":[33],"One":[34],"many":[37],"mechanisms":[38],"for":[39,132,180,203,260,265,449],"transmembrane":[43],"drug":[44,127,147,181,269,391],"efflux":[45],"pump":[46,89],"p-glycoprotein,":[47],"encoded":[48],"by":[49,211],"gene":[51],"MDR1.":[52],"It":[53,153],"has":[54],"been":[55],"shown":[56],"that":[57,111,156,173,228],"overexpression":[58],"this":[60],"protein":[61],"in":[62,142,149,241,275,279,297,311,317,364,373,385,403,436],"cancer":[64,158,184,438],"associated":[66,367,388],"with":[67,160,196,225,243,287,313,336,368,389,408],"poor":[68],"chemotherapeutic":[69],"response":[70,372,382],"and":[71,99,121,131,135,166,190,207,213,223,236,244,251,263,282,350],"multidrug":[72],"due":[74,324],"low":[76,351],"intracellular":[77,295],"accumulation":[78],"drug.":[81],"Its":[82],"wide":[83],"substrate":[84],"specificity":[85],"allows":[86],"it":[87],"out":[90],"several":[91],"common":[92],"drugs":[93,227,384],"such":[94,233,248],"as":[95,176,209,220,234,249],"vincristine,":[96],"paclitaxel,":[97],"doxorubicin,":[98],"etoposide.":[100],"Biodynamic":[101],"imaging":[102,441],"(BDI)":[103],"a":[105,177,369,386,416],"low-coherence":[106],"form":[107],"digital":[109],"holography":[110],"provides":[112,122],"deep":[113],"3D":[114,221],"functional":[115],"information":[116],"on":[117],"intratumor":[118],"subcellular":[119],"motility":[120],"spectral":[123,178,256,354,381,398],"signatures":[124,172,355],"related":[125],"mode":[128,392],"action":[130],"mitosis,":[133],"apoptosis,":[134],"necrosis.":[136],"BDI":[137],"currently":[139],"being":[140],"used":[141,240,310],"clinical":[143],"trials":[144],"identify":[146,415],"patient":[150],"tumor":[151,185],"biopsies.":[152],"was":[154,258,285,303,309,400],"hypothesized":[155],"spheroids":[159,186,222,333,344,411],"varying":[161,197],"degrees":[162,198],"platinum":[164,205],"p-glycoprotein":[167,171,208,231,246,378],"would":[168],"identifiable":[170],"could":[174],"serve":[175],"biomarker":[179],"resistance.":[182],"Ovarian":[183],"from":[187],"A2780":[189,318],"SKOV3":[191,332,374],"cell":[192,283],"lines":[193],"were":[194,218,239,273,334],"cultured":[195,277],"cisplatin":[200],"select":[202],"increasing":[204],"detected":[210],"immunofluorescence":[212],"western":[214],"blot":[215],"analysis.":[216],"Cells":[217],"grown":[219],"treated":[224,335,343],"anticancer":[226],"are":[229,412],"known":[230],"substrates":[232],"doxorubicin":[235],"paclitaxel.":[237,331],"Treatments":[238],"combination":[242,312],"without":[245],"inhibitors":[247],"verapamil":[250,308,337],"zosuquidar.":[252],"For":[253],"BDI,":[254],"background":[255],"data":[257],"collected":[259],"3":[261],"hrs":[262,267],"then":[264],"9":[266],"treatment.":[270],"Parallel":[271],"experiments":[272,405,407],"done":[274],"2D":[276],"cells":[278],"96-well":[280],"plates":[281],"viability":[284],"assessed":[286],"XTT":[289],"assay.":[290],"A":[291,395],"suppression":[292],"average":[294],"motion":[296],"low-frequency":[299],"range":[300],"(0.01":[301,352],"Hz)":[302,349,353],"observed":[304,402],"when":[305],"20":[306],"\u00b5M":[307,315,340],"10":[314,339],"paclitaxel":[316],"cells.":[319],"This":[320],"result":[321],"may":[322],"be":[323],"microtubule":[327],"stabilizing":[328],"effect":[329],"plus":[338],"doxorubicin.":[341],"Doxorubicin":[342],"increased":[346],"high":[347],"(10":[348],"indicative":[356],"apoptosis.":[358],"Addition":[359],"MDR1":[361,397,409,435],"modulators":[362],"resulted":[363],"frequency":[365],"changes":[366],"greater":[370],"apoptotic":[371],"spheroids.":[375],"Modulation":[376],"alters":[379],"manner":[387],"action.":[394],"specific":[396],"signature":[399],"not":[401],"these":[404],"but":[406],"silenced":[410],"underway":[413],"possible":[417],"signature.":[418],"Citation":[419],"Format:":[420],"Gayatri":[421],"Narayanan,":[422],"David":[423],"D.":[424],"Nolte,":[425],"Daniela":[426],"Matei,":[427],"Ran":[428],"An,":[429],"John":[430],"J.":[431],"Turek.":[432],"Investigation":[433],"using":[439],"biodynamic":[440],"[abstract].":[442],"In:":[443],"Proceedings":[444],"American":[447],"Association":[448],"Cancer":[450,463],"Research":[451],"Annual":[452],"Meeting":[453],"2017;":[454],"2017":[455],"Apr":[456],"1-5;":[457],"Washington,":[458],"DC.":[459],"Philadelphia":[460],"(PA):":[461],"AACR;":[462],"Res":[464],"2017;77(13":[465],"Suppl):Abstract":[466],"nr":[467],"2046.":[468],"doi:10.1158/1538-7445.AM2017-2046":[469]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-08-08T00:00:00"}